# Targeting the Hippo Transducer TAZ in Breast Cancer With Statins

> **NCT02416427** · PHASE2 · UNKNOWN · sponsor: **Regina Elena Cancer Institute** · enrollment: 78 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT02416427
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2015-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02416427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02416427, "Targeting the Hippo Transducer TAZ in Breast Cancer With Statins". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02416427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*